Stance Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,213
Closed -$4.15M 287
2025
Q4
$4.15M Buy
20,213
+1,692
+9% +$318K 1.53% 10
2025
Q3
$2.91M Buy
18,521
+767
+4% +$118K 1.07% 25
2025
Q2
$2.98M Sell
17,754
-17,470
-50% -$2.59M 1.12% 12
2025
Q1
$4.85M Buy
35,224
+35,220
+880,500% +$4.49M 3.59% 5
2024
Q4
$473 Buy
+4
New +$467 ﹤0.01% 244

Other funds holding CAH

Stance Capital's CAH Position: Q1 2026 in Review

Stance Capital sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 20,213 shares — an estimated $4.15M sold.

Stance Capital first reported a position in CAH in Q4 2024 and held it in 5 quarters. The position peaked at $4.85M in Q1 2025. 1,424 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Stance Capital reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
  • Stance Capital sold 20,213 Cardinal Health shares in Q1 2026, an estimated $4.15M.
  • Stance Capital first reported a position in Cardinal Health in Q4 2024 and held it in 5 quarters.
  • Stance Capital's Cardinal Health position peaked at $4.85M in Q1 2025.
  • 1,424 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.